Type 1 Diabetes
Market Overview
The global Type 1 Diabetes (T1D) market size was approximately US $34.87 billion in 2024 and is projected to reach about US $74.03 billion by 2034, demonstrating a Compound Annual Growth Rate (CAGR) of 7.82% during the period from 2024 to 2034.
Summary
Introduction to T1D
Nature of the Disease: Type 1 Diabetes (T1D) is an autoimmune disease.
Pathological Mechanism: The immune system attacks and destroys the insulin-producing beta (β) cells in the pancreas, preventing the body from secreting sufficient insulin.
Common Onset Age: It is most commonly diagnosed in children and adolescents, but it can develop at any age.
Primary Impact: Due to the lack of insulin, patients must rely on exogenous insulin therapy to maintain blood glucose balance.
Product Development Progress
